Use of biomaterials in the reconstruction of posterior lamellar eyelid defects: a systematic review and meta-analysis.
Rehman U, Shemie M, Sarwar MS, Adebayo O, Brennan PA.
Br J Oral Maxillofac Surg. 2023 Sep;61(7):464-474. doi: 10.1016/j.bjoms.2023.06.001. Epub 2023 Jun 15.
Long-Term Outcomes of Acellular Dermal Allograft as a Tarsal Substitute in the Reconstruction of Extensive Eyelid Defects.
Vahdani K, Siapno DL, Lee JH, Woo KI, Kim YD.
J Craniofac Surg. 2018 Jul;29(5):1327-1331. doi: 10.1097/SCS.0000000000004464.
Reconstruction of an Eyelid Defect Associated with Congenital Coloboma in a 7-Month-Old Male Infant Using an Acellular Dermal Allograft.
Cao W, Li L, Fan Y, Wang Y, Wu Q.
Am J Case Rep. 2024 Feb 10;25:e942645. doi: 10.12659/AJCR.942645.
Conjunctival-limbal autograft.
Daya SM.
Curr Opin Ophthalmol. 2017 Jul;28(4):370-376. doi: 10.1097/ICU.0000000000000385.
Causes and Surgical Outcomes of Lower Eyelid Retraction.
Kim KH, Baek JS, Lee S, Lee JH, Choi HS, Kim SJ, Jang JW.
Korean J Ophthalmol. 2017 Aug;31(4):290-298. doi: 10.3341/kjo.2016.0059. Epub 2017 Jul 4.
Subconjunctival injections of dimethyl fumarate inhibit lymphangiogenesis and allograft rejection in the rat cornea.
Yu J, Li Y, Li Z, Li H, Chen Y, Chen X, Su W, Liang D.
Int Immunopharmacol. 2021 Jul;96:107580. doi: 10.1016/j.intimp.2021.107580. Epub 2021 Apr 3.
Conjunctival transplantation.
Thoft RA.
Arch Ophthalmol. 1977 Aug;95(8):1425-7. doi: 10.1001/archopht.1977.04450080135017.
Limbal Stem Cell Transplantation and Complications.
Yin J, Jurkunas U.
Semin Ophthalmol. 2018;33(1):134-141. doi: 10.1080/08820538.2017.1353834. Epub 2017 Nov 27.
Case series: The use of a dehydrated human amnion/chorion membrane allograft to enhance healing in the repair of lower eyelid defects after Mohs micrographic surgery.
Wisco OJ.
JAAD Case Rep. 2016 Jul 27;2(4):294-7. doi: 10.1016/j.jdcr.2016.06.002. eCollection 2016 Jul.
Split-Thickness Skin Grafts.
Braza ME, Marietta M, Fahrenkopf MP.
2025 Feb 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
